Maven Securities LTD Purchases Shares of 100,000 Medline $MDLN

Maven Securities LTD purchased a new stake in Medline (NASDAQ:MDLN) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 100,000 shares of the company’s stock, valued at approximately $4,200,000.

A number of other hedge funds have also recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Medline in the fourth quarter valued at approximately $63,000,000. Brown Advisory Inc. bought a new position in Medline in the fourth quarter valued at approximately $5,112,000. Kestra Advisory Services LLC bought a new position in Medline in the fourth quarter valued at approximately $98,000. Maverick Capital Ltd. bought a new position in Medline in the fourth quarter valued at approximately $33,435,000. Finally, Marshall Wace LLP bought a new position in Medline in the fourth quarter valued at approximately $6,110,000.

Analyst Ratings Changes

MDLN has been the subject of a number of analyst reports. Weiss Ratings downgraded Medline from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 15th. Evercore restated an “outperform” rating and issued a $55.00 price target on shares of Medline in a research note on Wednesday, February 25th. BMO Capital Markets raised their price target on Medline from $45.00 to $54.00 and gave the company an “outperform” rating in a research note on Thursday, February 26th. BNP Paribas Exane reduced their target price on Medline from $49.00 to $40.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Finally, Royal Bank Of Canada lifted their target price on Medline from $47.00 to $53.00 and gave the stock an “outperform” rating in a research note on Thursday, February 26th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $50.54.

Insider Activity at Medline

In other news, insider Jessi L. Corcoran purchased 5,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $34.15 per share, with a total value of $170,750.00. Following the acquisition, the insider owned 5,000 shares in the company, valued at approximately $170,750. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Medline Stock Performance

Shares of NASDAQ MDLN opened at $36.61 on Monday. The company has a debt-to-equity ratio of 0.65, a current ratio of 4.41 and a quick ratio of 2.51. Medline has a 12 month low of $32.81 and a 12 month high of $50.88. The business’s 50 day simple moving average is $40.76. The company has a market cap of $48.09 billion and a P/E ratio of 114.41.

Medline (NASDAQ:MDLN) last issued its earnings results on Wednesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.29 by $0.04. The business had revenue of $7.35 billion for the quarter. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. Analysts predict that Medline will post 1.51 EPS for the current fiscal year.

Medline Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.